| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Email: |
eric_feng1954@126.com |
| Products Intro: |
Product Name:Varespladib Methyl
CAS:172733-08-3
Purity:95% -98%HPLC Package:1GR;10GR;50GR;100GR;250GR;500GR;1KG;5KG;10KG;100KG
|
|
| Product Name: | S-3013 | | Synonyms: | A-002;S-3013;Varespladib Methyl;Acetic acid, 2-[[3-(2-amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]-, methyl ester;inhibit,Phospholipase,Inhibitor,A002,Varespladib methyl,LY 333013,LY-333013,A 002;methyl 2-((3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetate;VARESPLADIB METHYL (LY333013) | | CAS: | 172733-08-3 | | MF: | C22H22N2O5 | | MW: | 394.42 | | EINECS: | | | Product Categories: | | | Mol File: | 172733-08-3.mol |  |
| | S-3013 Chemical Properties |
| Melting point | 172-187 °C | | Boiling point | 624.6±65.0 °C(Predicted) | | density | 1.26±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: 100 mg/mL (253.54 mM) | | form | Solid | | pka | 12?+-.0.50(Predicted) | | color | White to off-white |
| | S-3013 Usage And Synthesis |
| Definition | ChEBI: Varespladib methyl is a methyl ester resulting from the formal condensation of the carboxy group of varespladib with methanol. It is a potential therapy for the treatment of snakebite envenomings in which toxicity depends on the action of PLA2s. It has a role as a prodrug, an anti-inflammatory drug, an antidote and an EC 3.1.1.4 (phospholipase A2) inhibitor. It is a methyl ester, an aromatic ether, a member of benzenes, a member of indoles and a primary carboxamide. It is functionally related to a varespladib. |
| | S-3013 Preparation Products And Raw materials |
|